Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/1996
05/15/1996EP0711161A1 Method to inhibit restenosis
05/15/1996EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
05/15/1996EP0711158A1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
05/15/1996EP0711157A1 Endothelin receptor antagonists
05/15/1996EP0711134A1 Medicinal for protection from neurological damage
05/15/1996EP0639192B1 (benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
05/15/1996CN1122601A |1,2,4¨triazolo|4,3-a¨ quinoxaline derivatives, their preparation and use
05/15/1996CN1122591A Large potassium bicarbonate crystals and process for the preparation thereof
05/15/1996CN1122331A Benzene, pyridine and pyrimidine derivative
05/15/1996CN1122329A Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
05/15/1996CN1122248A Insulin analog formulations
05/14/1996US5516807 Administering a polyamine to a patient to treat or prevent restenosis
05/14/1996US5516805 Antiischemic agents, anticarcinogenic agents and antiarrhythmia agents for cardiovascular disorders
05/14/1996US5516783 Platelet activating factor
05/14/1996US5516774 Treating diseases characterized by excess renal reabsorption of water
05/14/1996US5516773 Agent for treating high blood pressure and cardiac insufficiency
05/14/1996US5516653 Genetic engineering
05/14/1996US5516526 Compositions containing DMSO and Fructose 1,6-diphosphate
05/10/1996CA2162342A1 Intravenous solutions for a derivative of staurosporine
05/10/1996CA2162341A1 Pharmaceutical carriers
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013506A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996WO1996013501A1 Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/09/1996WO1996013499A1 Apolipoprotein-b synthesis inhibitors
05/09/1996WO1996013492A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
05/09/1996WO1996013489A1 Process for the preparation of tetrazoles
05/09/1996WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis
05/09/1996WO1996013479A1 Nitro-benzamides useful as anti-arrhythmic agents
05/09/1996WO1996013274A1 Process for production of inhibited forms of activated blood factors
05/09/1996WO1996013269A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996DE4439477A1 Use of alpha-liponic acid, its isomers and derivs.
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2203814A1 Nitro-benzamides useful as anti-arrhythmic agents
05/09/1996CA2203807A1 Process for production of inhibited forms of activated blood factors
05/09/1996CA2203767A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996CA2202881A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/08/1996EP0710665A1 Phosphonosulfonate squalene synthetase inhibitor salts and method
05/08/1996EP0710658A1 5-(Aryloxymethyl)oxazolines, process for their preparation and pharmaceutical compositions containing them
05/08/1996EP0710657A1 Antagonists of adhesion receptors
05/08/1996EP0710646A1 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710236A1 Azalicyclooctane derivatives as anti-arrhythmic agents
05/08/1996EP0710235A1 Endothelin antagonists
05/08/1996EP0710233A1 Heteroaryl cycloalkenyl hydroxyureas
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710116A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
05/08/1996EP0710113A1 Preparation for improving the blood supply containing hard magnetic particles
05/08/1996EP0585440B1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
05/08/1996EP0517778B1 Vasoactive vasotocin derivatives
05/08/1996CN1122138A Foldback triplex-forming oligonucleotides
05/08/1996CN1121828A Medicinal health beverage formulation
05/08/1996CA2161936A1 New 1,5-disubstituted 7a-methylperhydroinden-3a-01 derivates, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
05/07/1996US5514706 Diabetes
05/07/1996US5514699 Pharmaceutical compounds
05/07/1996US5514690 Potassium channel activators, antiischemic, antiarrhythmic
05/07/1996US5514680 Glycine receptor antagonists and the use thereof
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/04/1996CA2159850A1 Phosphonosulfonate squalene synthetase inhibitor salts and method
05/02/1996WO1996012800A1 Modified factor vii
05/02/1996WO1996012797A1 Production and use of human and plant methyltransferases
05/02/1996WO1996012715A1 Cyclopropachromenecarboxylate derivatives
05/02/1996WO1996012697A2 Calcium receptor-active compounds
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
05/02/1996WO1996012480A1 Polyamine compounds for treating vascular proliferative disorders
05/02/1996WO1996012479A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996CA2203280A1 Modified factor vii
05/02/1996CA2203271A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996CA2203265A1 Production and use of human and plant methyltransferases
05/02/1996CA2198914A1 Polyamine compounds for treating vascular proliferative disorders
05/01/1996EP0709386A1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/01/1996EP0709384A1 Benzylpiperidine derivatives having high affinity for binding sites of aminoacid receptors
05/01/1996EP0709383A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
05/01/1996EP0709382A1 Aromatic dibenzofurane derivatives, pharmaceutical and cosmetic compositions containing them
05/01/1996EP0709376A2 Therapeutic compounds
05/01/1996EP0709375A2 Therapeutic heterocycles
05/01/1996EP0708778A1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists
05/01/1996EP0708774A1 Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996CN1121722A Spirostanyl glycosidal crystalline monohydrate
05/01/1996CN1121720A Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
05/01/1996CN1121690A Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/01/1996CN1121689A Use of indole derivatives as 5HT1 antagonists
05/01/1996CN1121414A Pharmaceutical containing noval 3,7-diazabicyclic |3,31¨-non-bilinking compound
05/01/1996CA2161618A1 Benzylpiperidine derivatives
04/1996
04/30/1996US5512681 Angiotensin II receptor blocking imidazolinone derivatives
04/30/1996US5512595 Substituted phenoxyisobutyric acids and esters
04/30/1996US5512573 Skin irritation; prevention transplant rejection
04/30/1996US5512572 Using ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl) hydrazono)propanedinitrile
04/30/1996US5512571 Diastereomeric intermediates which form levorotatorycardiotonic agents having high bioavailability
04/30/1996US5512563 Tricyclic benzazepine vasopressin antagonists
04/30/1996US5512558 Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
04/30/1996US5512286 Extract from leaves of ginkgo biloba for intravenous injection or infusion
1 ... 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 ... 1595